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 Positron Emission Tomography (PET) using 18F-FDG is playing a vital 
role in the diagnosis and treatment planning of cancer. However, the 
most widely used radiotracer, 
18
F-FDG, is not specific for tumours and 
can also accumulate in inflammatory lesions as well as normal 
physiologically active tissues making diagnosis and treatment planning 
complicated for the physicians.  Malignant, inflammatory and normal 
tissues are known to have different pathways for glucose metabolism 
which could possibly be evident from different characteristics of the 
time activity curves from a dynamic PET acquisition protocol. 
Therefore, we aimed to develop new image analysis methods, for PET 
scans of the head and neck region, which could d ifferentiate between 
inflammation, tumour and normal tissues using this functional 
information within these radiotracer uptake areas. We developed 
different dynamic features from the time activity curves of voxels in 
these areas and compared them with the widely used static parameter, 
SUV, using Gaussian Mixture Model algorithm as well as K-means 
algorithm in order to assess their effectiveness in discriminating 
metabolically different areas. Moreover, we also correlated dynamic 
features with other clinical metrics obtained independently of PET 
imaging. The results show that some of the developed features can 
prove to be useful in differentiating tumour tissues from inflammatory 
regions and some dynamic features also provide positive correlations 
with clinical metrics. If these proposed methods are further explored 
then they can prove to be useful in reducing false positive tumour 
detections and developing real world applications for tumour diagnosis 
and contouring. 
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Medical imaging is the field of acquiring and analysing images of internal structures 
and functions of the body that can aid in diagnosis of a disease and also assist in its 
treatment planning (LeVine, 2010).  Out of various available medical imaging 
techniques, positron emission tomography (PET) imaging with the 
18
F-FDG radiotracer 
has been used for decades for the diagnosis of cancer and its utilization in the process of 
radiotherapy planning is also increasing with the passage of time . Several studies have 
demonstrated the effectiveness of PET in intensity modulated radiation therapy (IMRT) 
planning and defining biological tumour volume (BTV) (Minn et al. , 2010). The 
radiotracer used in PET imaging accumulates in different areas of the body depending 
upon its intrinsic properties and acquired PET images represent these areas of higher 
radiotracer accumulation as regions of higher intensity or ‘hot-spots’. However, the 
most widely used radiotracer, 
18
F-FDG – an analogue for glucose, is not specific for 
tumour tissues and it can also accumulate in benign inflammatory or infectious lesions, 
similar to that of tumours, because of higher glucose metabolism in those particular 
areas (Bahkeet and Powe, 1998). This limitation of 
18
F-FDG radiotracer makes the 
image interpretation challenging particularly in the imaging of head & neck region 
where, quite commonly, tumour and inflammation reside close to each other and 
differentiation of areas of higher uptake into malignant, benign, inflammation and 
normal tissue becomes crucial for the optimum diagnosis and radiotherapy planning 
(Yao and Faulhaber, 2012).  
 
In PET, activity concentration of the radiopharmaceutical is first measured in units of 
Becquerels per millilitre (Bq/ml). For imaging, particularly in oncologic PET, this unit 
is commonly converted to standardised uptake values (SUVs). However, SUV 
calculation introduces other limitations as well as those of the tracer, regarding the 
adequate differentiation of functionally distinct metabolic areas. SUV is calculated by 
aggregating the PET signal over a selected time window, typically several minutes, and 
afterwards normalising it with respect to patient’s body mass and initial concentration 
of the injected radiotracer. As well as losing dynamic information in the temporal 
aggregation, SUV also depends upon many other confounding factors which include 
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PET frame duration, patient’s diet, scanning protocol and image reconstruction (Thie, 
2004; Boellaard, 2009). While basing judgement for tissue discrimination exclusively 
on SUV, dynamics of the radiotracer accumulation in the tissues are being neglected as 
it is relying primarily on the averaged concentration over time.   
 
The reason for the elevated glucose or 
18
F-FDG radiotracer metabolism in the tumour 
and inflammation is multifactorial; some of these factors that have been mentioned by 
Gillies et al. (2008) and Plathow et al. (2008) are due to the up-regulation of glucose 
transporters (GLUTs) and increased enzymatic activity of hexokinase proteins. The up-
regulation of the GLUTs leads to enhanced tumour glucose metabolism (Younes et al., 
1997). Increased level and activity of the hexokinase enzymes is also another reason for 
increased uptake of 
18
F-FDG in the tumour cells. Jadvar et al. (2009) have postulated 
that there can be a different level and extent of GLUT and hexokinase expression in 
normal tissue, cancer and inflammatory regions which can be evident in the different 
temporal profile of 
18
F-FDG uptake in these different areas. On the basis of that 
acquired information the areas of FDG uptake, which may be similar looking in a static 
time averaged PET image, can be differentiated based on their temporal profile.  
 
Dynamic PET acquisitions are gaining interest for radiotherapy nowadays because 
radiotracer metabolism in the area of interest can be followed with the time profile 
(Muzi et al., 2012; Shepherd and Owenius, 2012a).  If we assume that there will be a 
different extent and level of GLUT and hexokinase expression in the tumour, inflamed 
regions and normal tissue surrounding tumours, then we can infer that the metabolic 
pathways in these areas will be different and with the aid of a dynamic PET acquisition 
protocol, a map of 
18
F-FDG radiotracer dynamics can be used to differentiate 
metabolically different areas.  
 
In summary, current imaging and image processing methods are limited for 
differentiating functional volumes of interest in FDG PET, and recent evidence suggests 
that dynamic PET can add relevant, discriminant information. This thesis presents a 
new dynamic imaging protocol for PET oncology, then develops and evaluates analysis 
techniques for the dynamic image data that aim to improve on SUV imaging for 
diagnosis and treatment planning. 
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2. Review of Literature 
 
2.1 Positron Emission Tomography 
 
Positron Emission Tomography, commonly known as PET, is a non-invasive imaging 
modality which uses radiopharmaceutical drugs to image molecular function. After 
injection of a radiopharmaceutical drug, it circulates throughout the entire body as a 
normal physiological mechanism and at the same time it starts accumulating at specific 
sites depending upon its binding properties (Saha, 2010). During the whole process the 
radiopharmaceutical keeps on emitting positrons as a process of nuclear decay. The 
reason for the process of nuclear decay, in these molecules, is a higher number of 
protons which makes nuclei unstable; as a result, a proton decays into a positron, a 
neutron and a neutrino. A positron is an antiparticle having a positive charge and mass 
equal to that of an electron; after emission, positrons travel some distance and collide 
with their antiparticles, electrons, by a process known as annihilation. The electrons 
involved in annihilation can belong to any molecular structure of any local tissue. The 
distance travelled by a positron before colliding with an electron depends upon energy 
with which it is emitted and density (electron) of the surrounding tissue. Annihilation 
converts mass m of these particles into energy e, according to the equation e=mc
2
, 
where c denotes the speed of light. This conversion produces energy in the form of two 
gamma photons travelling in opposite directions to each other (almost 180
o
) from the 
point of annihilation and having energy of 511 KeV. These emitted gamma photons are 
detected by the PET camera detectors which are designed in such a way that they 
surround the patient’s body in a form of a ring (Figure. 1 & Figure 2A). Imaging is 
based on the assumption that any pair of photons that arrive opposite to each other, and 
at the same time, originate from the same annihilation event. The device estimates the 
‘line of response’ between the two detectors corresponding to one annihilation, and the 
actual point of annihilation along that line is estimated for all annihilations in a single 
time frame by a reconstruction algorithm, which also uses the time difference between 
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paired photons reaching the detectors. All the acquired raw data are sent to the 




Figure 1: Diagrammatic representation of the PET detectors designed such a way that 
they surround the patient’s body. Gamma photons, produced as a result of annihilation, 
are detected in coincidence by the PET detectors and it is marked as one single event.  
 
 
Figure 2 shows the scanner used for all PET imaging in this study. It is a hybrid PET-
CT device that also acquires X-ray CT images of the patient for attenuation correction 
and for anatomical reference by fusing with PET. The device also has time of flight 
technology to improve the PET resolution; with the aid of this technology the location 
of the annihilation is also estimated by the time difference (of the order nanoseconds) 
between two photons reaching detectors.  
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Figure 2: Photographs of the opened up gantry of PET-CT scanner (General Electric 
Discovery 690 PET-CT Scanner) A. PET assembly of the scanner; red arrows point to 
PET detectors (bottom left) and photo multiplier tubes (top right). B. CT assembly of the 
scanner; red arrows point to x-ray tube (right) and x-ray detectors (left). Image 






F-FDG – Fluorodeoxyglucose  
 
18
F-FDG, which is an analogue for glucose and has a half-life of 110 minutes, is the 
most commonly used radiotracer in the PET imaging (Delbeke et al., 2002). In 
particular, it is very useful in oncological PET examinations because of the observation 
that rapidly dividing tumour cells require higher energy in the form of adenosine tri-
phosphate (ATP) and cells generally fulfil their energy requirement by the process of 
breaking down glucose known as glycolysis (Miles and Williams, 2008). In order to 
have higher energy, cells need to take in higher amounts of glucose and during PET 
examinations 
18
F-FDG, being a glucose analogue, accumulates at the area of higher 
glucose utilization. Over time as the tracer washes away from tissue regions that do not 
capture FDG in this way, the regions of FDG utilization become most visible in PET 
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images. A more detailed description of the mechanism of glucose and 
18
F-FDG 
metabolism in tumours, normal and inflammatory tissues is given in section 2.3. 
 
2.1.2 Imaging Protocols  
 
PET scans can be acquired with two main types of acquisition protocol, static and 
dynamic. Static scanning acquisition protocols are the most commonly employed 
nowadays when imaging for radiotherapy treatment planning. In these protocols the 
scanning is started a certain period of time after radiotracer injection and the activity 
concentration of the radiotracer is measured over a fixed period of time, around 2 to 5 
minutes. For the static scan, with 
18
F-FDG radiotracer, typical clinical practice is to start 
image acquisition after approximately 60 minutes of radiotracer administration 
(Boellaard et al. , 2010). 
 
With the aid of dynamic PET acquisition protocol, activity of the radiotracer can be 
measured at multiple time points and this activity concentration plotted against time to 
form time activity curves (TACs). A TAC provides information about the kinetics of the 
radiotracer in the specific tissue and at the same time gives insight about the rate of 
tracer in and out flux and amount/rate of tracer accumulation (Thorwarth et al. , 2005).   
 
The whole body scan of a typical adult cannot be done in a single bed position because 
the field of view (FOV) governed by the assembly of the PET detectors is not big 
enough to cover all the body regions at the same time. Whole-body PET acquisitions 
are therefore made from a series of multiple bed positions. At each bed posit ion, the 
scanner acquires data for the set period of time and then moves along in the axial 
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2.1.3 Image Analysis 
 
After PET acquisitions and image reconstructions have been done, a 3D image volume 
is produced for the image analysis purposes. Inside an image-volume, each individual 
voxel (volume cell) represents the activity concentration in the corresponding 
anatomical tissue (Cherry, 2006). Size of the voxel depends upon the image 
reconstruction algorithm employed. In a typical image, having 3.27mm slice thickness, 
in-slice field of view 70 x 70 cm and matrix grid-size 192 x 192, each of the voxels 
represent 0.0435 cm
3
 (3.65 x 3.65 x 3.27mm) of the corresponding anatomical tissue. 
On a normal image display the radioactivity concentration is represented as a certain 
value of grey scale (or pseudo colour). In clinical practice this activity concentration is 
normalised with respect to the injected radioactive concentration and patients’ body 
mass and commonly referred to as standardised uptake value (SUV). The SUV is 
calculated using the following equation,  
 
    
                      
                           
 
          (Equation 1) 
 
This measurement of SUV is treated as an index for tissue metabolism as well as degree 
of malignancy (Nahmias and Wahl, 2008). Figure 3 shows typical PET images (fused 
with CT images for anatomical reference) of the head and neck region obtained using 
18
F-FDG radiotracer. The intensity of each PET voxel is in units of SUV. 
 
It has been documented that SUV is a semi quantitative value and has several pitfalls; 
various factors can produce inconsistent results for the same volume of interest. These 
factors include patient’s body size, time of image acquisition  after injection, patient’s 
plasma glucose level, and possible dose extravasations (Lin and Alavi, 2009). Laffon et 
al. (2011) proposed a method of adjusting SUV for injection-acquisition time 
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differences, but the method has limited practicality in the current clinical setting and 
until now is only validated in cases of lung cancer.  
 
Figure 3: Axial sections of fused PET and CT images of head and neck region; the 
patient has palatine tonsil carcinoma. 
18
F-FDG radioactivity concentration has been 
shown on the SUV scale. Multiple uptake areas represent higher glucose metabolism 
within those regions. 
 
 
Moreover, while imaging with 
18
F-FDG radiopharmaceutical, thyroid glands, lymph 
nodes, myocardium, site of infection, skeletal muscle, and benign pathological FDG 
uptake in healing bones can represent similar SUV to that of cancer and thus cause 
interpretive pitfalls (Shreve et al. , 1999).  
 
Several methods have been suggested in order to differentiate similar looking uptake 
areas on the PET images. Some of the studies have suggested using dual time point PET 
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acquisition protocol; Zuhang et al. (2001) using dual time point imaging showed that 
the SUV of benign lung nodules slightly decreased, while average SUV of the 
malignant lesion increased in the second time point. Similarly, Chui et al. (2012) 
reported a successful discriminatory technique using dual time PET acquisition protocol 
for differentiating malignant solid lung nodules from benign ones. Basu et al. (2009) 
have shown similar phenomena over an extended period of time (upto 8 hours) in 
patients of lung carcinoma; Lodge et al. (1999) observed that FDG uptake in high grade 
sarcomas continued to increase for up to four hours whereas FDG uptake came to an 
equilibrium state within thirty minutes in normal tissues; however, any particular 
imaging analysis technique or imaging protocol has not been suggested, leaving the 
issue unresolved. Hustinx et al. (1999) also utilised a dual time point imaging protocol 
in head and neck cancer patients and suggested that if the two scanning sessions are 30 
minutes apart then the tumour uptake of FDG may be distinguishable from those of 
normal and inflamed tissues based on the change in activity concentration.  
 
By using full dynamic imaging of several time points, compartmental modelling has 
also been used in various researches for the quantification of radiotracer kinetics within 
the tissue of interest (Morris et al., 2004). However, compartmental modelling is limited 
for applications in radiotherapy treatment planning. One limitation is the arterial input 
function that needs to be provided; this function is derived from the radioactivity 
concentration within the blood supply, measured at various time points. Measurement 
of radioactivity concentration within blood supply require repetitive blood sampling 
during the period of scanning which increases patient discomfort as well as work 
burden for the operators. Another limitation is that models are sensitive to noise and are 
therefore calculated for spatially averaged TACs within pre-defined volumes of interest.   
  
2.2 Head and Neck Carcinoma 
 
In head and neck malignancies the most common type of malignant tumour is the one 
that originates from the surface of the squamous epithelium and it is commonly known 
as Squamous cell carcinoma (SCC) (Wenig and Cohen, 2009). SCC of head and neck 
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region is newly diagnosed for over half a million patients annually worldwide (Minn et 
al., 2010) and it also represents 2-4% of all the malignant conditions in United States 
(Carvalho et al. , 2005). 
 
Cigarette smoking and alcohol consumption are the most common causes of the 
development of head and neck malignancies (Lewin et al., 1998). Moreover, Human 
papillomavirus (HPV) has been reported to be associated with SCC (mainly 
oropharyngeal) of head and neck regions (Syrjänen and Syrjänen, 2000).   
 
SCC can be further classified into different grades based on histopathologic 
characteristics. Under high magnification, the more tumour resembles the appearance of 
a cell and/or tissue layer from which it has arisen, the better differentiated it is.  If seen 
using microscope with proper staining, a well differentiated SCC has obvious 
keratinisation and intercellular bridges, and it is given grade I; moderately differentiate 
carcinoma is labelled as grade II, poorly differentiated as grade III and undifferentiated 
as grade IV. (Wenig and Cohen, 2009.) 
 
As part of the diagnosis in the case of head and neck cancer, physicians also assign a 
certain stage (commonly known as TNM staging) based upon anatomic extent of the 
primary tumour (T), the involvement of regional lymph nodes (N) and distant 
metastasis (M) (Sobin, 2003).  
 
Syrjänen (2004) has mentioned that tonsils, composed of many crypts, are mainly 
populated by lymphocytes and their surface is covered by stratified squamous 
epithelium, while a similar surface also lines the crypts. It has been believed that HPV 
associated tonsillar SCC originates from the epithe lium of the crypts, while non-HPV 
associated SCC arise from tonsillar surface epithelium (Frisch et al. , 2000 and 
Hemminki et al. , 2000).  
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2.3 Mechanism of Glucose / 18F-FDG Metabolism 
 
Glucose is metabolised in tissues with the help of the glucose transport protein: GLUT. 
GLUT is involved in the first rate-limiting step for glucose metabolism that allows 
energy independent glucose transport across the cell membrane down the concentration 
gradient (Macheda et al., 2005). The mechanism of the metabolism of glucose, as well 
as the glucose analogue
 18
F-FDG used in PET imaging, is described in detail below for 
different tissues i.e. normal tissue, head and neck tumours and inflammatory tissues.  
 
2.3.1 Normal tissue  
 
Sugar, mainly glucose, is one of the major sources of energy to a normal animal cell.  
For cells to take in polar molecules like glucose, the molecules need to cross a semi-
permeable plasma membrane with the aid of membrane-associated carrier proteins. 
GLUT is one of the families of these membrane-associated glucose transporter proteins 
which use the gradient of sugar concentration inside and outside the plasma membrane 
to facilitate glucose movement through that membrane (Calvo et al. , 2010). Following 
entry of the glucose molecules into the normal cells, they are converted to pyruvate as a 
result of glycolysis. Pyruvates subsequently change into acetyle-CoA which is 
afterwards used by mitochondria to generate ATPs (Szablewski, 2013). Hexokinase 
enzyme binds to the mitochondrial membrane and phosphorylates glucose to glucose-6-
phosphate using the energy produced by the mitochondria. The end product of this 
glucose metabolism in a normal cell, under aerobic conditions, is carbon dioxide and 
water. Similarly, 
18
F-FDG is phosphorylated to FDG-6-phosphate, but contrary to 
glucose-6-phosphate, it cannot be metabolised further in the glycolytic pathway and 
becomes trapped in the cell because of its negative charge.  
 
2.3.2 Head and Neck tumours  
 
Basic glucose metabolism reactions in tumour cells are similar to the normal tissues 
mechanisms; however, in case of FDG metabolism in the tumours cells, the low activity 
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of the reverse enzyme, glucose-6-phosphotase, leads to the tumour cell accumulation of 
FDG-6-phosphate which is visible in the PET images as bright spots because of the 
abundant annihilation reactions at the corresponding location of the patient’s body and 
by the complex process of image formation described earlier in this document in section 
2.1.  
 
On the basis of sequence similarity GLUT has been divided into three classes (Class I, 
II & III) and each class is further subdivided into different subcategories. Class I 
consists of GLUT-1, GLUT-2, GLUT-3, GLUT-4; Class II consist of GLUT-5, GLUT-
7, GLUT-9, GLUT-11 and Class III consist of GLUT-6, GLUT-8, GLUT-10, GLUT-
12. It has also been reported that the glucose transport proteins involved in the transport 
of glucose across the tumour cells’ membrane express themselves in tissue-specific 
fashion. GLUT-1 and GLUT-3 have been reported to be involved in the basal glucose 
uptake of extra-cranial head and neck tumours (Mellanen et al. , 1994) while GLUT-2 & 
GLUT-4 have not been detected. Several studies have also mentioned that GLUT-1 and 
GLUT-3 gene expression have been found to be higher within tumour cells of head and 




Essentially, glucose transport mechanism is the same in inflammatory tissues as it is in 
normal tissues; however, it has been reported that the expression of glucose transporter 
proteins may be different in inflammatory tissues as compared to norma l and cancerous 
tissues. White blood cells and platelets are abundant in inflammatory tissues (Bailey et 
al., 2006) and GLUT-3 has been reportedly detected in platelets, as well as in the entire 
set of white blood cells (lymphocytes, neutrophils, monocytes and macrophages) (Calvo 
et al., 2010). GLUT-3 has higher affinity for the transport of glucose molecules 
compared to GLUT-1 (Simpson et al. , 2009).  
 
As it has been documented in the published literature, there is difference in the 
mechanism of glucose metabolism in tumours, compared to other metabolising tissues.  
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It is reasonable to expect that this difference can be observed in the TACs of different 
areas using 
18
F-FDG radiotracer, and that tissue discrimination can be based on those 
differences in TACs.   
 
2.4 18F-FDG PET Imaging of Head and Neck Carcinomas 
 
PET imaging fused with CT has been reported to be of high diagnostic performance in 
the assessment of head and neck cancers (Gordin et al., 2007). 
18
F-FDG PET alone has 
been found to be more accurate in detecting primary as well as metastatic disease in 
head and neck region as compared to CT or MRI (Adam et al. , 1998; Kresnik et al., 
2001; Haerle et al. , 2011); however, PET offers limited anatomical demarcation; 
therefore, it is combined with another imaging modality, commonly CT or MRI for 
tumour delineation as well as for precise anatomical differentiation. Moreover, PET is 
also reported to be a highly useful imaging modality in detecting any residual or 
recurrent tumour in head & neck after radiation therapy or surgery (Hubner et al., 
2000).  
 
Despite the high sensitivity and specificity of PET in detecting tumours of the head and 
neck region, there are still problems with the delineation of the gross tumour volume 
(GTV) with PET imaging for radiotherapy planning. As well as limitations of the 
imaging technology such as low resolution and partial volume effects (Zaidi et al., 
2009) the processes governing the tracer uptake and washout over the period of time are 
complex, and not clear in SUV images. For example, more than one process such as 
metabolism and hypoxia can act together, and inflammation may be present to some 
extent within a tumour region, making static 
18
F-FDG PET alone insufficient for 









In general terms, classification is a method of identifying a category for a new 
observation on the basis of data that have already been categorised based on some 
chosen features (Pham and Bazin, 2008). Classification is a fundamental tool in medical 
imaging. In screening for breast cancer for example, analysis of the whole 
mammograph may be used to classify a patient as normal or suspected of disease. 
Furthermore, within diseased patients, tumours can be further classified, e.g. Guo et al. 
(2009) showed that characterisation and classification of tumour lesions is possible 
using computerized fractal-based texture analysis in digital mammograms.  
 
Feature selection and extraction are important steps used in classification of medical 
images, which means selecting the subset of features that are more likely to distinguish 
one tissue class or patient diagnosis from another (Hall et al., 1971). As in this thesis, 
voxels may be labelled as belonging to a functional or anatomical class based on the 
chosen features.  
 
In order to first identify features on which classification can be based, clustering can be 
used; where clustering is a technique of grouping data in such a way that the data points 
in the same cluster are more similar to each other than to other data points in other 
cluster, based on the chosen features (Ng et al., 2006). There are several clustering 
algorithms proposed for the classification of data; however, discussing each of them is 
beyond the scope of this thesis document. Generally, classification algorithms have 
been divided into two main classes, parametric and non-parametric, and for the purpose 
of classification of our data we choose to use one common classification algorithm from 
each of these main classes. Another distinction can be made between supervised and 
non-supervised classification algorithms. Supervised methods use labelled training data 
to create inferred functions so that new observations from outside the training set can be 
assigned to the already defined classes using training data. Unsupervised classification 
algorithms do not require training data; rather, they divide observations into a (usually 
pre-defined) number of classes. 
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In our present study we consider one PET voxel as one observation or data point so that 
the task becomes classifying image regions according to their tissue function. We also 
decided to investigate those properties on the basis of which we can cluster data points 
of the same volume of interest (VOI) together and differentiate them somehow from 
other VOIs. These features or properties were investigated and derived from the time 
activity curves (TACs); these are further discussed in detail in section 4.4. We aimed to 
use two clustering algorithms, Gaussian Mixture Model (GMM) clustering algorithm 
and K-means clustering algorithms; these algorithms have been discussed one by one in 
detail below. 
 
2.5.1 The Gaussian Mixture Model 
 
Gaussian Mixture Model is a parametric method of unsupervised clustering in which 
there are no predefined classes and the algorithm assumes all the data points to be 
normally or Gaussian distributed. The complete Gaussian mixture model is 
parameterized by the mean vectors, covariance matrices and mixture weights from all 
component densities (Ion, 2011).  
 
The Gaussian mixture model can be generally represented by the following equation: 
 
                        
 
   
 
          (Equation 2) 
 
Where x is the D-dimensional continuous-valued feature vector with mean vector μ and 
covariance matrix Σ and wi (i = 1…m) are the mixture weights from all component 
densities; m is the number of classes and in the case of binary classification m is equal 
to 2 (Reynold, n.d). GMM parameters are estimated from a given dataset using an 
optimization algorithm, for example the iterative Expectation-Maximization (EM) 
algorithm; initially, assumptions are made about parameters µ and ∑, and then the 
estimates are iteratively refined in order to maximize the likelihood of the observed data 
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according to those parameters. The advantage of using EM algorithm is its capability 
for handling uncertainties within a given dataset (Dempster et al., 1977; Bishop, 2006).  
 
GMM has been used previously in various medical image segmentation techniques; 
Górriz et al., (2009) has used GMM in three dimensional functional brain images to 
divide images into clusters according to region of low and high activation using the 
intensity distribution of the voxels. The resulting ROIs are claimed to be useful in 
computer aided diagnosis of brain diseases like Alzheimer’s disease.  
 
In our study we also aimed to differentiate different VOIs using this clustering 
algorithm based on feature vectors obtained from TACs of the different VOIs. GMM 
assumes the feature vector to be Gaussian distributed; however, some of the feature 
vectors obtained from the TACs might not be normally distributed thus causing 
difficulty for the GMM algorithm to differentiate between the two different classes. In 
this situation K-means algorithm can in principle demonstrate better results as 
compared to GMM algorithm.    
 
2.5.2 K-means Clustering Algorithm 
 
The K-means clustering algorithm is an unsupervised learning algorithm belonging to 
the non-parametric class of clustering algorithms. It follows a simple way to classify a 
given data into a predefined number of clusters (k) (Pham et al. , 2000). The algorithm 
works such that each of the data point’s membership is determined by approximating 
the centroid for each cluster and assigning each data point to the cluster with the nearest 
centroid (Su and Chou, 2001); for minimizing the cluster point dispersion the algorithm 
iteratively relocates the centroid point of each of the k clusters (Oyelade et al., 2010). 
 
This clustering algorithm is widely being used for medical image segmentation in 
several areas of research; however, the use of this algorithm for the differentiation of 
different metabolic areas in PET images is limited. Jansen et al. (2009) utilised a K-
means algorithm to classify PET images based on a single feature: the slope of the time 
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activity curves obtained from PET images of the rectal cancer patients. The method 
distinguished tumour from healthy tissue and provides motivation for further use of 
dynamic PET classification such as in this thesis. 
 
2.5.3 Classifier Performance Evaluation 
 
In order to measure the performance achieved by our chosen classification algorithms 
we used different performance evaluation techniques. One of the ways for evaluating 
the success of a classification algorithm is receiver operating characteristic (ROC) 
analysis. A ROC curve is a plot of the sensitivity of an algorithm’s classification versus 
1-specificity or false positive rate (FPR) for different thresholds of a controlling 
parameter (Park et al., 2004; Murphy, 2007). The area under the curve (AUC) produced 
by the ROC analysis can be used as a combined measure to evaluate the sensitivity and 
specificity of the performance of the classifier algorithm (Metz, 2006) and it is closely 
related to Wilcoxon rank-sum test (Hanley and McNeil, 1982; Mason and Graham, 
2002).  For the performance evaluation of our GMM we used AUC of the ROC curve; 
whereas, in order to measure success of K-means clustering algorithm we directly used 
the sensitivity and specificity of the success of the classifier. In a classification 
experiment, sensitivity may refer to the proportion of the true positives correctly 
identified as such; whereas, specificity may refer to the proportion of the negatives 
which are correctly identified (Altman and Bland, 1994).  
 
All of the above performance measures require some definition of ‘truth’ used in 
counting true/false positive and negative classifications. In general, test data should be 
independently labelled as belonging to one class or the other. In medical imaging, 
without using simulated or phantom data, the best available approximation of truth is 
used and is never perfect (Shepherd et al. , 2012b). The gold-standard method is to use 
manual delineation, revisited in section 4.3.1.  
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The aims of this master’s thesis were to present a new dynamic PET imaging 
acquisition protocol for head and neck cancer imaging and radiotherapy planning and to 
devise new image analysis techniques for tissue discrimination, with particular 
reference to contouring for treatment planning. Moreover, it also intended to compare 
the new analysis methods with standard methods in terms of sensitivity and specificity 





The thesis work was based on the following broad hypothesis: 
 
 Features derived from time activity curves (TACs) using dynamic PET can 
differentiate disease from inflammation and healthy tissue with significantly higher 
sensitivity and specificity than currently used, static parameters.  
 
Later on, specific hypotheses were tailored according to early results and the nature of 
arising test data; these hypotheses are: 
 
H1: Uptake areas of inflammation can be better differentiated from tumour areas using 
dynamic features, derived from TACs, compared to SUV. 
 
H2: Healthy tissue surrounding tumour can be better differentiated from tumour tissue 
using features, derived from TACs, compared to SUV. 
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H3: Normal physiological uptake areas can be differentiated from tumour’s uptake  
regions using features derived from TACs. 
 
H4: Mean dynamic feature (extracted from TACs) of tumour VOIs better discriminate 
between tumours of different stages compared to SUV.  
 
H5: Mean dynamic feature (extracted from TACs) of tumour VOIs better discriminate 
between tumours of different grades compared to SUV. 
 
H6: Mean dynamic feature (extracted from TACs) of tumour VOIs better discriminate 












20 | P a g e  
 




In total five patients (age 58 to 65 years; all males) were included in the study , all 
having squamous cell carcinoma (SCC) of head and neck region. Patients were 
numbered one to five and in order to maintain patient confidentiality, patients’ ID, name 
and other personal information were removed from the meta-data of those images that 
were intended to be used for research purposes. Patients 1 – 3 had palatine tonsils 
carcinoma whereas patient 4 had carcinoma of the base of tongue and patient 5 had 
oropharyngeal carcinoma. Detailed patients’ information is given in table 1. 
 













T N M 
1 63 Tonsillar ca. 2 2B 0 III Posit ive 320.39 
2 65 Tonsillar ca. 3 2B 0 II Posit ive 309.04 
3 59 Tonsillar ca. 2 2B 0 II Posit ive 298.33 
4 59 Base of tongue ca. 3 2B 0 II Posit ive 293.77 
5 58 Oropharyngeal ca 3 2B 0 I Negative 283.87 
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4.2 Scanning Protocol 
 
Patients, with known head and neck cancer, were scanned in treatment planning 
position with the GE Discovery 690 hybrid PET-CT scanner (CT: 64-slices; PET: LBS 
crystals, 47 transverse slices of 3.27 mm slice thickness, axial FOV 15 cm) at Turku 
PET Centre, Turku University Hospital, Finland using 
18
F-FDG as radiotracer. All 
patients fasted for at least 4 hours before the scan. None of the patients had received any 
treatment intervention (radiotherapy, chemotherapy or surgery) before the PET 
imaging. Patients were positioned supine on a flat scanner table and immobilised with 
the help of restraining devices including thermoplastic face mask specifically moulded 
to each patient. For the delivery of the radiotracer, catheter lines were placed in the 
patient’s body to provide the intravenous vascular access.  
 
Figure 4 diagrammatically represent the whole scanning protocol along with time. A CT 
scan of the body (from the level of eyebrow to that of  thorax) was acquired for the 
planning of PET scanning and afterwards a bolus of radiopharmaceutical drug (
18
F-
FDG) was administered and dynamic PET scan was initiated instantaneously; 
acquisitions were performed for up to 30 minutes and the dynamic data were 
reconstructed in 20 time frames. After this first, dynamic acquisition session the patients 
rested outside the scanner before a second session began.  
 
After 70 minutes of the FDG injection, a routine PET-CT scan (from the level of the 
eye brow to that of the kidney) was performed in the second imaging session 
comprising static acquisitions that covered the whole body in four bed positions. The 
first two bed positions were imaged with four minutes acquisition time, and contain the 
neck region corresponding to the 30 minutes dynamic acquisitions. These were 
followed by the remaining two bed positions with two minutes acquisition time. The 
resulting whole-body PET/CT scan gives the same static image used in routine 
treatment planning.  
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Still during the second imaging session, after 95 minutes of radiotracer injection, another 
static PET scan was performed only of the neck region with four minutes acquisition 
time. The two static images of the neck region are appended to the dynamic acquisitions 
to create a total of 22 dynamic frames. 
  
Figure 4: Diagrammatic representation of the scanning protocol which was designed 
for this study. An initial CT scan was made for planning purposes of the PET scans and 
afterwards PET scanning was performed immediately after the injection of 
radiopharmaceutical drug FDG; twenty PET frames were acquired within  the first 30 
minutes. Later, in the second scanning session a whole body CT scan was acquired 
which was part of routine diagnostic scan followed by whole body PET scan. Lastly, a 
PET acquisition of the neck region was also obtained which made in total twenty two 
dynamic PET frames of the neck region. 
 
Image reconstruction was done with an iterative VUE Point Fx method (GE Healthcare, 
2011) with 2 iterations and 24 subsets. A reconstruction matrix of 192 x 192 and FOV 
70 cm was used. After reconstruction and decay correction, images of the static 
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acquisition at the 21
st
 time point (70-75 minutes & 4 minutes frame length) were used in 
order to generate SUV images according to equation 1 (section 2.1.3). We calculated 
SUV for the entire image used in treatment planning as well as separately for all those 
voxels which were present within our VOIs. 
 
4.3 Extracting Volumes of Interest  
 
4.3.1 Contouring tumour and inflammation 
 
As mentioned in section 2.5.3, our experiments require independent approximation of 
tissue classes in an image, for use in classifier evaluation. As a part of patient’s normal 
treatment planning protocol, a qualified radiation oncologist drew 3 dimensional (3D) 
contour sets around the tumours. These contours were drawn manually, on SUV images 
from the 21
st
 time frame, as part of clinical treatment planning procedure required for 
intensity modulated radiation therapy (IMRT) and also used as the best available ‘truth’ 
in classifier evaluation.  
 
All of the patients underwent dental extractions before the start of their treatment 
because periodontal infections during cancer therapy may lead to significant morbidity 
and mortality (Epstein and Moore, 2001); therefore, patients also had 
18
F-FDG uptake at 
the site of dental extraction due to the presence of inflammation at those sites and these 
areas could also be used as inflammatory VOIs. The radiation oncologist also drew 
contours around these dental inflammatory regions of uptake.  
 
All of these contours were drawn on the spatially co-registered PET/CT images because 
CT has higher resolution and provides better anatomical visualisation and demarcation 
than PET imaging (Gordin et al., 2007); the corresponding PET voxels of these CT 
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4.3.2 Automatic method of healthy tissue definition 
 
As part of this thesis research, a method was devised for isolating PET voxels 
surrounding the tumours , providing ‘ground truth’ for the class of normal tissue 
immediately outside of the tumour. This is an important class because, for the purpose 
of automated GTV contouring, it is exactly these voxels that should be distinguished 
from tumour. These voxels were isolated by automatically defining a three dimensional 
regular shaped bounding box around the irregular shaped tumour , to enclose all tumour 
voxels, and subtracting those voxels from bounding box which belonged to tumour 
class (Figure 5 C). Finally, those voxels were also excluded, which had high tracer 
uptake and were included in other nearby VOI contours (e.g. inflammation, lymph 
node) thus representing any other metabolic process. 
  
 
Figure 5: Procedure (shown only in 2 dimensions) of extracting voxels from volume of 
interest contours. A. All initial contours were delineated on the CT scan images B. 
Process of the identification of the corresponding PET imaging voxels as that of 
particular VOI contours. C. The automatic method of acquiring the PET voxels 
immediately surrounding the tumours (red) representing normal tissue (blue). 
 
 
As well as healthy tissue around tumours, physiological uptake that was observed at the 
site of palatine tonsil in the case of one patient was also delineated using an automated 
method; a regular shaped three dimensional bounding box was defined manually around 
the area of physiological uptake and afterwards those voxels were excluded which had 
less than 50% of the maximum SUV (SUVmax).  
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For the five head and neck patients included in our study, 5 tumour VOIs, 8 
inflammation VOIs, 5 healthy tissue VOIs and 1 physiological uptake (palatine tonsil) 
VOI were defined both by manual as well as automated delineation methods. These 
delineations provide ‘ground truth’ for training and evaluating classification 
experiments, as well as validation by correlation with clinical data. However, it should 
also be noted that manual contours do have inevitable expert subjectivity and tendency 
to include some ambiguous tissue near the boundary in order to avoid under-
segmentation. All these VOIs are mentioned in table 2 along with their total volume in 
cm
3
 and number of voxels in PET space. Moreover, the anatomical locations of these 
VOI have been shown in figure 5 and Appendix A includes all the fused PET-CT 
images of these VOIs along the craniocaudal axis. All inflammation classes are labelled 
as left- or right-inflammation according to location in the image (e.g. ‘left 
inflammation’ in figure 6 A ii) rather than the patient’s frame of reference. 
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Figure 6: Fused PET-CT images of the patients showing anatomical location of the 
VOIs included in the study. A. Patient 1 images, red coloured bounding box encloses  i) 
tumour located at palatine tonsil, ii) inflammation within right jaw at the site of dental 
extraction, iii) inflammation within left jaw at the site of dental extraction. B. Patient 2 
images, red coloured bounding box encloses  i) tumour located at palatine tonsil,  ii) 
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normal physiological uptake of radiotracer within palatine tonsil, iii) inflammation 
within right jaw at the site of dental extraction iv) inflammation within left jaw at the 
site of dental extraction. C. Patient 3 images, red coloured bounding box encloses  i) 
tumour located at palatine tonsil, ii) inflammation within right jaw at the site of dental 
extraction iii) inflammation within left jaw at the site of dental extraction. D. Patient 4 
images, red coloured bounding box encloses  i) tumour located at base of tongue, ii) 
inflammation within left jaw at the site of dental extraction. E. Patient 5 images, red 
coloured bounding box encloses  i) oropharyngeal carcinoma, ii) inflammation within 
left right at the site of dental extraction. 
 
Table 2: Details of all VOIs included in the study acquired by manual as well as 





Total Volume in 
cm3 
1 
Tumour 201 9.97 
Inflammation Left 33 1.79 
Inflammation Right 36 1.64 
Healthy Tissue 255 12.55 
2 
Tumour 106 5.26 
Inflammation Left 9 0.45 
Inflammation Right 39 1.93 
Healthy Tissue 134 6.59 
Physiological Uptake 96 4.72 
3 
Tumour 237 11.76 
Inflammation Left 32 1.58 
Inflammation Right 26 1.29 
Healthy Tissue 225 11.07 
4 
Tumour 524 25.99 
Inflammation Right 12 0.60 
Healthy Tissue 569 28.01 
5 
Tumour 1488 73.80 
Inflammation Left 10 0.50 
Healthy Tissue 1742 85.74 
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4.4 Dynamic Features Computation from TACs 
 
From the generated TACs (one per voxel) a number of proposed features were 
calculated with the aim of differentiating TACs belonging to different tissue groups 
based on their shape, slope or other dynamic properties. The properties that were chosen 
for investigation are those that seemed to differ between classes in training data by 
visual inspection, or that may reasonably be expected to be influenced by different 
mechanisms of glucose transport. In total we developed seven dynamic features denoted 
D1, D2, D3...D7. Each of these feature’s mathematical derivation is described below, 
along with possible relevance to the biological characteristics of tissues following on 
from knowledge of the mechanisms described in section 2.3. All of these computations 
were performed in the programming software Matlab (Version: R2006b). 
 
4.4.2 D1: Retention Index 
 
Retention Index has been used earlier in various dual time point 
18
F-FDG studies which 
have been described in section 2.1.3. It represents fractional or percentage change in the 
activity concentration between an early time point and late time point of the PET scan. 
Findings of Higashi et al., (2002) suggested that the retention index can be an indicator 
of hexokinase II expression and it might be an indicator of phosphorylation rate in the 
area of interest. In our experiments we calculated the retention index using the 
following formula, 
                 
             
      
 
(Equation 3) 
Where, A is the activity concentration at a specific point of time. As mentioned in 
section 4.2, our scanning protocol had 22 PET frames; for Alate we used the activity 
concentration in the 21
st
 PET frame and for Aearly we used the mean activity 
concentration of the first 10 PET frames. 
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4.4.2 D2: Early Slope 
 
The slope of the TAC in the first 30 minutes was also used as a feature which may have 
the possibility to differentiate between tissues of different predominant function but 
similar long term uptake. Early slope of the TAC was calculated using following the 
formula of simple slope, 
              
                                  
                                 
 
          (Equation 4) 
where T is the time of that PET frame. 
 
4.4.3 D3: Area under the TAC20-21 
 





 minute) and the 21
st
 PET frame (~70
th
 minute). Area under the curve 
between these two time points was computed using the following formula, and 
graphical explanation of the equation has been shown in figure 7.  
 
                         
                   
 
   
(Equation 5) 
 
where B is equal to               (see figure 7 for graphical explanation)  
 
30 | P a g e  
 
 
Figure 7: Graphical representation of the mathematical derivation of D3 feature where 
area under the TAC of 20 and 21 PET frame is computed. Area under the TAC20-21 is the 
sum of [(T21-T20) × (A21-A20)/2] and B; where B is equal to [(T21-T20) × A20]. 
 
 
4.4.4 D4: Sum Fluctuation1-22 
 
Fluctuations in the activity concentration in TAC at a particular voxel might be 
representing flux in and out of the 
18
F-FDG radiotracer within that particular 
corresponding area; and the sum of all these fluctuations could possibly represent total 
radiopharmaceutical flux in-out capacity of the corresponding tissue. Where 
fluctuations (changes over small time differences) are small, it might be argued that 
they are largely governed by imaging noise; however, it should be noted that different 
VOIs belonging to the same PET image will suffer equal amounts of imaging noise and 
therefore features based on summing all these fluctuations is technically justified. The 
sum of fluctuations was computed using the following formula, 
 
                                                        
(Equation 6) 
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4.4.5 D5: Variance of local change 
 
Next we quantify the variance in the local change in activity concentration, over the 
extended period of time. This variance within a single PET voxel, is one way to 
characterise the overall shape of the TAC from that voxel, governed by the in-flux and 
out-flux of the radiotracer within the corresponding tissue. This feature is unique in the 
sense that it does not depend upon the final accumulative activity concentration within a 
tissue; rather, it represents the capacity of the corresponding tissue for the in-flux and 
out-flux of the radiotracer. For the purpose of calculation is variance Matlab’s built-in 
function ‘var’ was used. 
                                                         
(Equation 7) 
 
where An is the activity concentration within the voxels at the n
th
 PET frame. 
 
4.4.6 D6: Temporal Variance 
 
Temporal variance of the entire time activity curve represents the total change in the 
radioactivity concentration over the entire period of time. The greater the temporal 
variance, the greater the activity concentration gained over the period of the whole 
TAC. This variance also reflects how quickly the signal becomes stable. However, it is 
one limitation of this feature that it cannot differentiate between those TACs which 
show early uptake and those which show greater activity concentration during the later 
time period. Temporal variance within a single TAC of each voxel was computed using 
Matlab’s built-in function for the calculation of the variance within a given sample, 
                                    
(Equation 8) 
 
where An is the activity concentration within the voxels at the n
th
 PET frame. 
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4.4.7 D7: Sum of three slopes  
 
As earlier mentioned, the slope of a TAC represents the trapping of 
18
F-FDG within the 
particular tissue. Three slopes of the entire TAC were individually calculated and 
afterwards summed. Graphical explanation of the feature has been shown in figure 8.  
 
                                            
          (Equation 9) 
where, 
         
                                
                         
  
          (Equation 9.1) 
         
        
        
 
(Equation 9.2) 
         
        




Figure 8: Graphical representation of the mathematical derivation of D7 feature where 
sum of three slopes over the TAC is computed. Slope 1 is the slope of the TAC over first 









 PET frame 
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4.5 Feature Classification and Classifier Performance 
 
To classify the features calculated for each of the voxels included in our study, we used 
GMM and K-means classification algorithms. These algorithms have already been 
described in section 2.5. First we applied the classification algorithm to a mixture of 
data belonging to two different classes, from the set of four namely tumour, healthy, 
inflammation and physiological uptake. The algorithms were set up to divide the 
mixture into two classes, i.e. the number of classes is known but the truth labels are not. 
Next, the algorithms assigned data with a label according to whether it belongs to the 
positive class (e.g. tumour) or negative class (e.g. healthy tissue).  
 
For evaluating the performance of the GMM algorithm, the labels produced by GMM 
were compared with truth labels using ROC analysis (section 2.5). The controlling 
parameter, which was varied in order to create the multiple points of a ROC curve, was 
simply a threshold on the feature value. Finally, area under the ROC curve (AUCROC) 
was considered as a measure for GMM classifier performance. AUCROC of maximum 
1.0 can only be achieved if there is perfect match of truth labels with all labels produced 
by algorithm.  
 
In the case of the K-means algorithm, the truth labels were compared with the label 
produced by the algorithm and afterwards sensitivity and specificity were calculated 
using the following formulae, 
 
            
                        
                                                   
 
         (Equation 10) 
 
            
                       
                                                  
 
         (Equation 11) 
 
All the classification and performance evaluation were also implemented in the 
programming software Matlab (Version: R2006b). K-means classification is a built-in 
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functions of the Matlab statistical toolbox package; whereas, GMM code was adapted 
from code taken from Simulink’s on-line archive of open-source libraries (Matlab 
Central – File exchange, 2013).  
 
Classifier performance of different computed dynamic features were also compared 
with the classification performance of the static parameter SUV. For each binary 
classification (e.g. tumour vs. normal tissue in the same patient) the performance 
(AUCROC value in the case of GMM or sensitivity/specificity in the case of K-means) of 
feature and SUV-based classification was compared using Wilcoxon rank-sum tests. 
These tests investigate the difference between classifier performances over the whole 
group of patients, and are preferred over a parametric test (e.g. Student’s t-test) for 
cases where the number of patients is low. We used the Wilcoxon test for those features 
which were showing apparent superior discriminatory power as compared to SUV, in 
order to reveal any statistically significant differences. 
 
4.6 Correlation with Complementary Data 
 
It was interesting to see if a feature derived from the dynamic data correlated with the 
information that has been obtained independently of the dynamic PET imaging 
protocol. We also tried to discover such correlations between the dynamic features and 
clinical complimentary data which includes tumour grade from histopathology, HPV 
status and T-stage (from TNM staging, discussed in section 2.2) of the patient. Such 
correlations provide extra evidence of the affinity of the image analysis methods for 
measuring molecular properties and any correlation could in principle mean that the 
expensive, invasive procedure of biopsy and genetic analysis could be replaced by 
further analysis of the data available from PET studies. 
 
Our complimentary data were either binary (HPV status) or ordinal (stage, grade) and 
was available for only five patients; therefore, we decided to use Wilcoxon rank-sum 
test to seek any significant difference between mean dynamic features of the entire 
tumour VOI belonging to different sub-categories (HPV, grade, stage). 
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5. Experiments and Results 
 
5.1 Data preparation 
 
Each of the voxels included in a VOI had a series of PET acquisition’s activity 
information along the set time profile which could be used to plot time activity curves 
(TACs); therefore, we plotted these activity intensities, obtained from PET images, 
along the time profile in order to see different trends of radiotracer dynamics in 
metabolically different tissues. These different time activity curves are shown in Figure 
9. Time activity curves provided us with information on the dynamics of tracer uptake 
and washout in the area of interest. As mentioned earlier, we assumed that the time 
activity curves of the area of inflammation, tumour and healthy tissue will be different 
because of different rate of metabolic activity & different metabolic pathways.  
 
In the TACs it is interesting to observe that the tumour class of the first three patients 
having tonsilar carcinoma has generally less activity concentration compared to the 
inflammatory class; while in the last two patients (non-tonsilar carcinomas) the tumours 
are showing very high activity concentration, higher than inflammatory regions. 
Moreover, visual inspection of TACs reveals that the shape of the time activity curve of 
the tumour class in the first three patients is different from the last two.   
 
The SUV for each of the voxe ls was calculated using the 21
st
 PET frame (70-75 minutes 
after radiotracer injection) using equation 1 (section 2.1.3). Mean SUV for the VOI was 
calculated by averaging all the SUVs present within a volume of interest, and similarly 
for the mean retention index. Table 3 shows the mean SUV and mean retention index 
for all of the VOIs included in our study. It is interesting to note that the tumour VOI of 
patients 4 and 5 (non-tonsilar carcinomas) have remarkably higher SUVs compared to 
the other three patients having tonsilar carcinomas. 
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Figure 9: Time Activity Curves were plotted for each of the voxels included in our study; 
the graphs on the left side show the raw TACs of all the voxels included in different 
VOIs, different colours represent their origin from a particular class, with colour 
coding explained in the key. The graphs on the right show the same averaged TAC 
belonging to different VOI along with error bars given by ± 1 standard deviation.     
 
Table 3:  Mean SUV and mean retention index of all the VOI included in the study. 
Patient 
Number VOI SUVmean R.Imean 
1 
Tumour 2.08 -23.24 
Inflammation Left 4.33 53.16 
Inflammation Right 4.29 31.14 
Healthy Tissue 1.51 -31.67 
2 
Tumour 2.56 -10.53 
Inflammation Left 3.94 -5.19 
Inflammation Right 2.88 19.45 
Healthy Tissue 1.73 -32.17 
Physiological Uptake 2.30 -11.14 
3 
Tumour 2.62 -22.89 
Inflammation Left 3.76 2.01 
Inflammation Right 4.41 13.57 
Healthy Tissue 1.28 -42.62 
4 
Tumour 7.32 40.44 
Inflammation Right 3.82 -5.68 
Healthy Tissue 1.98 -32.29 
5 
Tumour 5.61 41.40 
Inflammation Left 2.35 -10.79 
Healthy Tissue 1.36 -51.59 
 
After the data preparation, a series of different experiments were performed on the 
available data; all the experiments were divided into three major groups, based on the 
VOIs to be compared, 
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- a. GTV and Inflammation experiments  
- b. GTV and normal tissue surrounding GTV experiments  
- c. GTV and Normal Physiological Uptake experiments  
 
The following subsections describe each of the performed experiments as well as their 
results; implications of the obtained results will be further analysed in the discussion 
section. 
 
5.2 Discriminating GTV from Inflammation 
 
Experiments for discriminating GTV from inflammation were set up to address 
hypothesis H1 (section 3.2).  
 
Gaussian Mixture Model classification was performed and area under the ROC curve 
was used as a combined measure for the sensitivity and specificity of the particular 
feature in successfully differentiating between two classes (Figure 11). 
 
Next, a K-means clustering algorithm was also utilised to automatically distinguish two 
classes. Performance of the K-means algorithm was evaluated in terms of sensitivity 
and specificity.  
 
We performed these experiments for all pairs of GTV and inflammation, and used a 
Wilcoxon rank-sum test to look for significant differences in performance between 
dynamic features and SUV, considering a significant cut off P-value of 0.05. 
 
Figure 10 shows the flowchart of all the experiments performed for differentiating GTV 
and inflammatory volumes, where Di is the dynamic feature calculated over the VOI  
and the same data flow is repeated for ‘i’ from 1 to 7 (D1, D2, D3...D7).  Figure 11 
graphically represents the results of the GMM algorithm and Figure 12 shows the 
results of the K-means algorithm, each showing selected results of the Wilcoxon test.  
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Figure 10:  Flowchart of the processes involved in the experiments of discriminating 
GTV from Inflammation.  
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Figure 11: GMM Algorithm results of discriminating between GTV and inflammation A: 
Showing aggregated results, along with error bars, in the form of ROC area under 
curve in all patients VOIs (In total 8 comparisons using one feature). The first navy blue 
coloured bar shows the ability of static parameter S1 (SUV) to successfully classify two 
classes while other bars show the ability of the dynamic features D1-7. B: Showing the 
performance of GMM classification algorithm in the patients having palatine tonsil 
carcinoma. C: Showing the performance of GMM classification algorithm in the 
patients having non-tonsil carcinoma (base of the tongue and oropharyngeal 
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carcinoma). The horizontal dotted blue line in A, B & C indicate level of static 
parameter S1 (SUV) to successfully classify two classes. D: Wilcoxon rank-sum test 
between the obtained AUC values of SUV and dynamic feature D3 in all of the patient’s 
VOIs (P=0.82). E: Wilcoxon rank-sum test between the obtained AUC values of SUV 
and dynamic feature D1 in VOIs of non-tonsil carcinoma patients (P=0.33). F: 
Wilcoxon rank-sum test between the obtained AUC values of SUV and dynamic feature 
D6 in VOIs of non-tonsil carcinoma patients (P=0.33). Error bars in all of the graphs 
represent ± 1 standard deviation. 
 
Figure 12: K-means algorithm results of discriminating between GTV and inflammation 
A: Showing aggregated results, along with error bars, in the form of sensitivity (i) and 
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specificity (ii) in all patients VOIs (in total 8 comparisons using one feature) and 
analysing 7 dynamic features. The first navy blue coloured bar shows the ability of 
static parameter S1 (SUV) to successfully classify two classes while other bars show the 
ability of the dynamic features. B: Performance of K-means classification algorithm in 
the patients having palatine tonsil carcinoma. C: Performance of K-means 
classification algorithm in the patients having non-tonsil carcinoma (base of the tongue 
and oropharyngeal carcinoma). (i) sensitivity of the algorithm in this subgroup (ii) 
specificity of the algorithm in this subgroup (iii) Wilcoxon rank-sum test between the 
sensitivities of SUV and dynamic feature D1 in patient’s VOIs of non tonsil carcinoma 
(P=0.33). The horizontal dotted blue line in the graphs represent level of static 
parameter S1 (SUV) to successfully classify two classes and error bars indicate ± 1 
standard deviation. 
 
The lower values of the area under the ROC curve (AUC) and lower values of 
sensitivity & specificity indicates that the classifier struggles to discriminate between 
inflammation and the GTV. It is interesting to observe that some developed features 
have better performance using one classification algorithm than the other one. Dynamic 
feature 3 (D3) has shown better discriminatory ability using GMM as compared to K-
means algorithm in patients with non-tonsil carcinoma.  
 
As mentioned in section 4, manual contours drawn by a radiation oncologist introduce 
inevitable expert subjectivity and there may be tendency to include some ambiguous 
tissue near the boundary in order to avoid under-segmentation; therefore VOIs from 
manual contours belonging either to GTV or inflammatory region may also contain 
some normal tissue voxels. As a result, ROC or sensitivity/specificity analysis using 
manual ground truth can give biased evaluation of classifier performance. In order to 
minimise the effect of subjective ground-truth we repeated classifier evaluation using 
ground truth obtained from an SUV thresholding technique. Starting with the manual 
contours (both GTV and inflammation), we thresholded those voxels which were 
showing less than 60% of the SUVmax; the voxels above this threshold were considered 
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to be purely representing one metabolic process (either cancer or inflammation). 
Afterwards, we used both of our class ification algorithms to compare these two classes 
(GTV and inflammation). Results of these experiments are shown in figure 13.  
     
 
Figure 13: Results of both GMM algorithm and K-means algorithm in discriminating 
GTV and inflammation after thresholding those voxels from manual contours which 
were showing less than 60% of SUVmax. A: GMM algorithm results in terms of AUC 
obtained from ROC analysis (i) results of all patients’ VOIs (ii) results of comparison of 
VOIs belonging to tonsil carcinoma patients (iii) results of comparison of VOIs 
belonging to non-tonsil carcinoma patients. B: K-means algorithm results in terms of 
sensitivity and specificity (i) results of all the patients’ VOIs (ii) results of comparison 
of VOIs belonging to tonsil carcinoma patients (iii) results of comparison of VOIs 
belonging to non-tonsil carcinoma patients. 
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It is interesting to observe in the results of the experiments performed using SUV 
threshold-based ground truth that the overall discriminatory power of almost all of the 
features increased; however, the overall relative trend in between the features remained 
the same.  
 
In all of these experiments some of the dynamic features showed better performance as 
compared to static parameter SUV (figure 11D, E, F & figure 12C iii); however, they 
were not able to provide any significantly superior performance considering a 
confidence level of 95%. Therefore, despite we found evidence in favour of the 
hypothesis, hypothesis H1 cannot be formally accepted. 
 
5.3. Discriminating GTV from Surrounding Tissue 
 
Clustering experiments were also performed for discriminating the GTV class from 
voxels immediately surrounding the tumours. Hypothesis H2, mentioned in section 4, 
led all these experiments. The same dynamic features were utilised to assess their 
usefulness in discriminating two classes using GMM & K-means clustering algorithms. 
Figure 14 shows a flowchart of the steps taken for these experiments, where Di is the 
feature calculated over the VOI  and the same data flow is repeated for ‘i’ from 1 to 7 
(D1, D2, D3...D7); figure 15 represents all of the results obtained.  
 
Figure 14:  Flowchart of the processes involved in the experiments of discriminating 
GTV from the healthy tissue surrounding tumour. 
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Figure 15: A: Results, along with error bars indicating ± 1 standard deviation, in the 
form of ROC area under curve of the Gaussian Mixture Model clustering in all of 
patients. The first navy blue coloured bar shows the ability of static parameter S1 
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(SUV) to successfully classify two classes while other bars show the ability of the 
dynamic features. B: Performance of GMM classification algorithm in sub-groups, 
graph on left: patients having palatine tonsil carcinoma; graph on right: patients 
having non-tonsilar carcinoma of head and neck region. C. Performance of K-means 
classification algorithm in terms of sensitivity and specificity of the developed features 
to discriminate between two classes (GTV and Healthy tissue surrounding tumour)in all 
patients’ VOIs. D: Performance of K-means classification algorithm in sub-groups (i) 
patients having palatine tonsil carcinoma; (ii) patients having non-tonsilar carcinoma 
of head and neck region. The horizontal dotted blue line in all of the graphs indicates 
that level of static parameter S1 (SUV) to successfully classify two classes. 
 
As the tumour contours have been manually drawn in CT space while keeping in mind 
PET uptakes on the SUV scale, it is therefore quite understandable that SUVs are 
showing better discriminatory power in both of the algorithms. However, it should also 
be noticed that SUVs are not showing maximum AUC or sensitivity/specificity of 1 
because SUVs are not the only parameter for tumour manual delineations by radiation 
oncologists. Possible application for these experiments could have been the automated 
tumour delineations based on dynamic features mimicking the manual contouring of 
radiation oncologists; and differentiation of tissue based on metabolic processes was not 
the prime objective; therefore, experiments with SUV thresholding technique were not 
performed in this subcategory of experiments. Keeping in view the results of these 
experiments we can deduce that hypothesis H2 cannot be formally accepted. 
 
5.4 Discriminating GTV from Normal Physiological Uptake 
 
In one of our tonsillar carcinoma patients (patient 2), there was bilateral FDG uptake in 
the palatine tonsil region; however, biopsy findings revealed the presence of tumour in 
the left side, while uptake on the contra-lateral side was classified as normal 
physiological uptake (Figure 16). We hypothesised that this similar looking normal 
physiological uptake can be differentiated from the tumour’s uptake based on our 
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Figure 16: Hybrid PET-CT static image of 
one of the patients (patient 2), included in 
our study showing multiple FDG uptake 
areas which can be visualised as bright 
spots on the SUV scale. Red arrow 
pointing bright spot as result of FDG 
uptake due to tumour in the palatine 
tonsil area (confirmed by biopsy findings) 
while the green arrow showing normal 
physiological uptake in the contra-lateral 
tonsil region. 
 
developed dynamic features (Hypothesis H3). Figure 17 show the flowchart of all the 
steps taken for these experiment where Di is the feature calculated over the VOI  and 
the same data flow is repeated for ‘i’ from 1 to 7 (D1, D2, D3...D7); figure 18 show all 





Figure 17:  Flowchart of the processes involved in the experiments of discriminating 
GTV from normal physiological uptake of the palatine tonsil. 
48 | P a g e  
 
 
Figure 18: Results of the experiments of discriminating GTV from Normal physiological 
uptake (NPU). A: Results in the form of ROC area under curve of the Gaussian Mixture 
Model clustering. The first navy blue coloured bar shows the ability of static parameter 
S1 (SUV) to successfully classify two classes while other bars show the ability of the 
dynamic features. B. Showing the performance of K-means classification algorithm in 
terms of sensitivity and specificity for its ability of the developed features to 
discriminate between two classes (GTV and physiological uptake in palatine tonsil). 
The horizontal dotted blue line in both A & B indicates level of static parameter S1 
(SUV) to successfully classify two classes. C: SUVmax values for the normal 
physiological uptake (NPU) and tumour VOIs. 
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Results of the GTV and normal physiological uptake experiments show that both of the 
algorithms struggle a great deal in order to discriminate between normal physiological 
uptakes and FDG uptakes from the palatine tonsil carcinoma. Both of these regions 
show similar patterns of uptake and washout that the dynamic features vectors obtained 
from TACs are incapable of differentiating between these two regions. Hence, clinical 
findings and histopathology remains very important in these circumstances. Resultantly, 
based on our obtained results, from only one patient’s data, we can deduce that 
hypothesis H3 cannot be accepted. 
 
5.5 Correlation Analysis 
 
As already mentioned in the section 4 we also seek to find correlation between mean 
dynamic feature of the tumour VOI and complimentary data obtained independently of 
the dynamic PET. We seek correlation between dynamic feature and the following 
complimentary data, 
a) T stage of the patient 
b) Histopathological grade of SCC 
c) HPV status of the patient 
The correlations were represented by P-value calculated using Wilcoxon rank-sum test, 
and were also compared for dynamic features and SUVs.  
 
5.5.1 Correlation between T-stage and Dynamic Feature (D1) 
 
The following experiment addresses hypothesis H4 by investigating correlation between 
T stage of the patients and dynamic features. We first evaluated the ability of the mean 
SUV of the entire tumour VOI to discriminate between the patients of different stages 








Figure 19: Relationship between T-stage and both static as well as dynamic features; A: 
Mean SUV and T-stage of the patient (P=0.4 between stages 2 and stage 3 patients); B 
Mean Dynamic feature D1 (retention index) and T-stage of the patient (P=0.2 between 
stages 2 and stage 3 patients).  
 
 
Results of these correlations provide evidence in favour of the proposed hypothesis H4 
and the hypothesis can be informally accepted as the P value obtained using dynamic 
feature (P=0.2) is closer to our significance cut-off value of 0.05 as compared to P value 
obtained using SUV (P=0.4); however, more data are needed to perform a robust, 
conclusive hypothesis test. 
 
5.5.2 Correlation between Histopathology SCC grade and Dynamic Feature (D5) 
 
To address hypothesis H5, we performed an experiment to evaluate correlation between 
histopathology SCC grade and dynamic features. We first evaluated the ability of the 
mean SUV of the entire tumour VOI to discriminate between tumours of different 
grades and later used our dynamic features. We found that our dynamic feature D5 
provides negative correlation with tumour grade. Figure 20 show the results of such 
correlation.  
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Figure 20: Relationship between histopathology SCC grade and both static (SUV) as 
well as dynamic feature (D5). A: Mean SUV and histopathology SCC grade (P=1 
(grade 1 & 2 or 1&3) and P=0.5 (grade 2 &3); B: Mean Dynamic feature D5 and 
histopathology SCC grade. (P=0.5 (grade 1 & 2 or 2&3) and P=1 (grade 2 &3) 
 
These results clearly show that dynamic feature (D5) can better discriminate between 
tumour of different grades as compared to the static parameter SUV and provide 
evidence in favour of hypothesis H5. This differentiation maybe because of the reason 
that tumours of different grades possibly have different glucose metabolic rates which 
dynamic feature 5 (D5) was successfully able to extract from TAC and effectively 
exploit in this analysis.  
 
5.5.3 Correlation between HPV status and Dynamic Feature (D5) 
 
The final experiment looks at the correlation between HPV status and dynamic features 
(hypothesis H6). We first evaluated the ability of the mean SUV of the entire tumour 
VOI to discriminate between tumours of different HPV status and later used our 
dynamic features. We found that our dynamic feature 5 also correlated with different 
HPV status. Figure 21 show the results, which suggest accepting our proposed 
hypothesis H6. 
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Figure 21: Relationship between HPV status and both static (SUV) as well as dynamic 
feature (D5); A: Mean SUV and HPV status (P=0.8); B Mean Dynamic feature D5 and 




However, it should be noticed that sample size in all of the correlation analyses was 
quite small as there were only five patients in our study. These results only provide an 
initiation point for further analysis and can prove to be useful if validated by analyzing 











We have evaluated and compared 19 VOIs belonging to tumour, inflammation, healthy 
tissue and normal physiological uptake regions, using 2 classification algorithms and 
utilising 1 static (SUV) and 7 dynamic features (from TAC). In total 5774 voxels 
belonging to these 19 VOIs were assessed using algorithms and their intrinsic uptake-
washout pattern over the 22 PET frames was exploited for differentiating metabolically 
distinct areas.   
 
We present the dynamic features computed from the time activity curves of the voxels; 
each of these features posses different biological meanings for the reason of radiotracer 
uptake-washout pattern and some of the features do not depend upon the final 
accumulated radioactivity concentration and exploit the information of the magnitude of 
flux in and out of the radiotracer or take into account total retention of radiotracer over 
the temporal profile.  
 
It is observed that the retention index (D1) in all of the patients’ healthy tissue VOIs are 
below -31 and the range is in between -52 to -31 (Table 3). Retention index for the 
tumours’ VOIs has a wide range, from -23 to 41, and it is encouraging to observe that 
there is no overlap between ranges of retention indices of normal tissue and tumour 
ones on VOI scale; therefore we can infer that the healthy and unhealthy tissue’s VOI 
can be differentiated based on their retention indices. Voxel-wise analyses using our 
clustering algorithms reveal that there are many voxels within the tumour’s manually 
delineated contours which are showing R.I similar to that of healthy tissue. It can be 
seen in figure 15 (C) that the R.I is showing higher sensitivity but low specificity which 
possibly indicates towards the presence of some voxels similar to negative class 
(healthy tissue) in the dataset of positive class (tumour). The reason for this is the fact 
that during delineation, radiation oncologist have the tendency to over segment the 
contours in order to not to miss any cancerous region for radiotherapy.  
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R.I of the palatine tonsil tumours’ VOIs (range -23 to -10) are less than that of other 
tumours of head and neck region (range 40 to 41) which means that tumours of the 
tonsils have less ability of retaining FDG within themselves (Table 3). There is still a 
gap in published scientific knowledge of the reasons for lower FDG retention in 
palatine tonsils.  
 
We have observed different shapes of the time activity curves within the same patients 
which represent different metabolic processes (Figure 9) and it was also interesting to 
see that the shape of time activity curves of tumour VOIs of the tonsil carcinoma 
patients were different from the non-tonsil carcinoma patients, despite the fact that they 
both belong to squamous cell carcinoma (SCC) of head and neck region (figure 22). It 
has been widely documented that tumours show steep rising curves (Sakamoto et al., 
1997); however, we noticed that while this trend is not very obvious in our palatine 
tonsil carcinoma patients, tumour VOI of non-tonsil carcinoma (base of tongue, 
oropharyngeal) do possess this attribute. Inflammation or benign tissue TACs are 
generally considered to have flat or downward curves (Gupta et al. , 1998); however, we 
also noticed great variability in this trend. Some of the inflammation TACs were 
showing steep rising curves compared to tumour ones (Figure 9) which may be because 
of the activity of more GLUT-3 in the inflammatory regions (section 2.3) and lesser in 
the cancerous region. Mellanen et al. (1994) has shown that there is generally lower 
expression of GLUT-3 proteins as compared to GLUT-1 proteins in squamous cell 
carcinoma (SCC) of head and neck region; and moreover it also has been reported that 
GLUT-3 has higher affinity for the transport of glucose molecules as compared to 
GLUT-1 (Simpson et al., 2009).  
 
Figure 22: Visual comparison of the shapes of the TACs of  the tumour class voxels; 
each plot represent mean TAC with error bar indicating ± 1 standard deviation; a) 
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Patient 1, palatine tonsil carcinoma; b) Patient 2, palatine tonsil carcinoma; c) Patient 




As previously mentioned, all of the inflammatory VOIs were obtained from sites of 
dental extraction.  We also tried to find correlation between the SUVs/dynamic feature 
vectors and the time between dental extraction and PET scan, but we did not find any 
such correlation (data not shown). The type of cells present at the site of dental 
extraction might be playing a vital role in determining the shape of TAC (Figure 9) and 
the type of cells at that particular dental site also depend upon the level of difficulty of 
the dental procedure (e.g. healing process: platelets) and any other on-going dental 
ailment. Moreover, because of dental extraction, that particular site may be undergoing 
the various phases of soft tissue healing and all of these phases have the inclination 
towards certain cells types i.e. coagulation (platelets), inflammation (neutrophils, 
macrophages, lymphocytes), fibroplasis (fibroblasts, epithelial cells, smooth muscles, 
endothelial cells), remodelling (fibroblasts, macrophages) and each of the cell type have 
different affinity for the level and extent of expression of glucose transport proteins 
(GLUTs). This can possibly explain the difference in the shapes of TACs of 
inflammation voxels in different patients. In addition to glucose metabolism and other 
molecular processes, the difference between TACs within a single patient is also 
governed by the variability of glucose availability and blood perfusion. If comparing 
TACs in between different patients it might also be different because of different 
cardiac and respiratory cycles.  
 
Some of the dynamic features are showing better sensitivity and specificity with K-
means clustering algorithm as compared to Gaussian Mixture Model clustering 
algorithm; this could be explained by some computations of the dynamic features 
producing feature vectors which were not normally distributed and GMM algorithm 
sometimes struggles in classifying two groups which are not distributed normally. The 
Lilliefors test, which is used to check whether the data are normally distributed or not, 
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can be used prior to a clustering algorithm and those feature vectors which do not fulfil 
the criterion of being Gaussian distributed can be classified using K-means algorithm. 
However, in our present study we aimed to use both of the algorithms and later on 
assess which algorithm produce better results. The use of Lilliefors test can also be 
helpful if some computer based application is developed for the automated image 
analysis. Some of the features are also showing opposite to what stated earlier and are 
demonstrating better results with GMM as compared with K-means algorithm which 
can be because of the reason that GMM utilises EM algorithm which estimates the 
maximum likelihood of the data point belonging to either of the classes. 
 
Physiological uptake at the site on palatine tonsil (patient 2) was showing the same 
uptake-washout pattern as compared to the tonsil carcinoma at the contra-lateral tonsil 
region. Dynamic features computed from TACs were unable to extract any information 
on the basis of which both uptake regions could be differentiated and classification 
algorithms also struggled to differentiate between these two classes (figure 18). Davison 
et al. (2010) has suggested that the SUVmax ratio (SUVmax of primary tumour/SUVmax of 
the contra-lateral tonsil) is a sensitive and specific parameter for differentiating benign 
metabolic activity from squamous cell carcinoma of palatine tonsil. We also utilised 
Davison et al. findings and calculated the SUVmax ratio; our region of normal 
physiological uptake was showing SUVmax of 4.08 and cancerous region SUVmax of 
3.48 (figure 18 – C) and its ratio was 0.85 which does not correlate with Davison’s 
findings.  
 
Our dynamic feature D5 was able to provide some correlation between the magnitude of 
the feature’s mean in the tumour VOI and histopathology grade of SCC. As explained 
in section 4.4.5, that this feature depends upon calculating the variance in the vector of 
local changes (in the consecutive PET frames) over the entire TAC of the particular 
voxel. We have seen in figure 20 that grade 1 tumours have more variance in the local 
changes vector, as compared to grade 2 and 3 tumours which possibly point out toward 
more flux in and out of the radiotracer in well differentiated squamous cell carcinoma as 
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compared to intermediate (grade 2) and poorly differentiated squamous cell carcinoma 
(SCC). 
 
In our scanning protocol we did not measure the blood glucose level of the patients 
prior to scanning; routine procedure at our hospital is to measure the glucose level of 
only those patients who have the history of diabetes. All patients are asked to fast four 
hours prior to scanning and it is considered that the patient will have blood glucose 
level within normal limits. However, we noticed surprisingly higher SUVs in patient 4 
(Table 3) which can be a result of normal blood glucose level irregularity; Busing et al.  
(2012) has also shown that blood glucose level (BGL) of the patients affect the bio-
distribution of the FDG in muscular tissue and brain; elevated BGL is associated with 
reduced cerebral FDG uptake and increased musculoskeletal uptake. However, they 
have also reported an interesting finding that BGL does not have any significant affect 
on the tumour uptake of FDG. For the future research we recommend that it will be 
valuable to measure blood glucose level in all of the patients irrespective of their 


















The total number of patients included in our study was relatively small and therefore the 
obtained results lack statistical power. Although some of the methods used in the 
experiments appear to be of promise in distinguishing either tumour from inflammation, 
or tumour from normal tissue; moreover, correlations between novel dynamic features 
and clinical information also demonstrate some encouraging outcomes. These results if 
developed further, using more patients’ data and multidimensional feature space of 
classification algorithms, may prove to be useful in developing real world applications 
for diagnosis, detection and contouring. Those dynamic features which have shown 
promising results for differentiating tumour from inflammation may prove to be useful 
in reducing false positive detection rates and those features that provide positive 
correlations between tumours of different grades, stage and HPV can be useful in 
diagnosis as well as understanding the disease itself.  
 
The main study outcomes are, 
- Dynamic features (D1, D3, and D6) provide some evidence of superior ability of 
differentiating tumour voxels from inflammatory voxels as compared to SUV 
which may assist physicians during PET image interpretations.  
- NPU and tumour of the palatine tonsil, within the same patient, may show 
similar radioactivity uptake washout patterns evident in TAC; therefore 
histopathological analyses remain important in these circumstances. 
- Dynamic feature D1 and D5 correlate with clinical parameters obtained 
independently of PET imaging (stage and grade - HPV status of the tumour, 
respectively).  
 
In conclusion, the present study has definitely opened some new doors for future 
research and highlighted the areas which need to be understood for further scientific 
development within this domain. Moreover, after further investigations, these methods 
can be applied in clinical setting and building up some computer based application for 
diagnosis, detection and contouring.  
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Figure Appendix A: Showing all the sections, along the craniocaudal axis, of all those 
VOIs which have considerable 
18
F-FDG uptake and were included in the study.  
 
 
 
 
 
 
 
 
 
 
 
 
